1. Home
  2. ISTR vs LCTX Comparison

ISTR vs LCTX Comparison

Compare ISTR & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Investar Holding Corporation

ISTR

Investar Holding Corporation

HOLD

Current Price

$27.25

Market Cap

268.9M

Sector

Finance

ML Signal

HOLD

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.68

Market Cap

407.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ISTR
LCTX
Founded
2006
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
268.9M
407.7M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
ISTR
LCTX
Price
$27.25
$1.68
Analyst Decision
Buy
Strong Buy
Analyst Count
1
4
Target Price
$29.00
$4.25
AVG Volume (30 Days)
43.4K
1.3M
Earning Date
01-22-2026
11-06-2025
Dividend Yield
1.61%
N/A
EPS Growth
24.14
N/A
EPS
2.22
N/A
Revenue
$93,426,000.00
$10,816,000.00
Revenue This Year
$7.24
$6.32
Revenue Next Year
$70.19
$124.49
P/E Ratio
$12.28
N/A
Revenue Growth
12.93
24.05
52 Week Low
$15.39
$0.37
52 Week High
$27.95
$2.09

Technical Indicators

Market Signals
Indicator
ISTR
LCTX
Relative Strength Index (RSI) 71.84 46.51
Support Level $27.04 $1.63
Resistance Level $27.95 $1.77
Average True Range (ATR) 0.51 0.07
MACD -0.02 -0.00
Stochastic Oscillator 71.86 28.21

Price Performance

Historical Comparison
ISTR
LCTX

About ISTR Investar Holding Corporation

Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

Share on Social Networks: